Access key information for investors, including company performance, governance, regulatory disclosures, and shareholder resources.
Manchester, 27 April 2021 – SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on the microbiome, announces that it has initiated a research and development programme in oral health with the University of Manchester (“the University”), as discussed when the Company executed its Placing in October 2020.